Ramandeep Rattan, Ph.D. - Publications

2006 Medical University of South Carolina, Charleston, SC, United States 
Cell Biology, Molecular Biology, Oncology, Pharmacology, Biochemistry

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Dar S, Chhina J, Mert I, Chitale D, Buekers T, Kaur H, Giri S, Munkarah A, Rattan R. Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells. Scientific Reports. 7: 8760. PMID 28821788 DOI: 10.1038/s41598-017-09206-0  0.48
2017 Wei X, Shi B, Koo I, Yin X, Lorkiewicz P, Suhail H, Rattan R, Giri S, McClain CJ, Zhang X. Analysis of stable isotope assisted metabolomics data acquired by GC-MS. Analytica Chimica Acta. 980: 25-32. PMID 28622800 DOI: 10.1016/j.aca.2017.05.002  0.48
2017 Mert I, Chhina J, Allo G, Dai J, Seward S, Carey MS, Llaurado M, Giri S, Rattan R, Munkarah AR. Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer. Gynecologic Oncology. PMID 28545687 DOI: 10.1016/j.ygyno.2017.05.019  0.48
2016 Mangalam AK, Rattan R, Suhail H, Singh J, Hoda MN, Deshpande M, Fulzele S, Denic A, Shridhar V, Kumar A, Viollet B, Rodriguez M, Giri S. AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage-Th17 Axis. Journal of Immunology (Baltimore, Md. : 1950). PMID 27354217 DOI: 10.4049/jimmunol.1501549  0.48
2016 Munkarah A, Mert I, Chhina J, Hamid S, Poisson L, Hensley-Alford S, Giri S, Rattan R. Targeting of free fatty acid receptor 1 in EOC: A novel strategy to restrict the adipocyte-EOC dependence. Gynecologic Oncology. 141: 72-9. PMID 27016232 DOI: 10.1016/j.ygyno.2016.02.026  0.48
2016 Hijaz M, Das S, Mert I, Gupta A, Al-Wahab Z, Tebbe C, Dar S, Chhina J, Giri S, Munkarah A, Seal S, Rattan R. Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer. Bmc Cancer. 16: 220. PMID 26979107 DOI: 10.1186/s12885-016-2206-4  0.48
2015 Poisson LM, Suhail H, Singh J, Datta I, Denic A, Labuzek K, Hoda MN, Shankar A, Kumar A, Cerghet M, Elias S, Mohney RP, Rodriguez M, Rattan R, Mangalam AK, et al. Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis. The Journal of Biological Chemistry. PMID 26546682 DOI: 10.1074/jbc.M115.679068  0.48
2015 Singh J, Deshpande M, Suhail H, Rattan R, Giri S. Targeted Stage-Specific Inflammatory microRNA Profiling in Urine During Disease Progression in Experimental Autoimmune Encephalomyelitis: Markers of Disease Progression and Drug Response. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 26277791 DOI: 10.1007/s11481-015-9630-0  0.48
2015 Al-Wahab Z, Mert I, Tebbe C, Chhina J, Hijaz M, Morris RT, Ali-Fehmi R, Giri S, Munkarah AR, Rattan R. Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction. Oncotarget. 6: 10908-23. PMID 25895126  0.48
2015 Poisson LM, Munkarah A, Madi H, Datta I, Hensley-Alford S, Tebbe C, Buekers T, Giri S, Rattan R. A metabolomic approach to identifying platinum resistance in ovarian cancer. Journal of Ovarian Research. 8: 13. PMID 25880539 DOI: 10.1186/s13048-015-0140-8  0.48
2014 Al-Wahab Z, Tebbe C, Chhina J, Dar SA, Morris RT, Ali-Fehmi R, Giri S, Munkarah AR, Rattan R. Dietary energy balance modulates ovarian cancer progression and metastasis. Oncotarget. 5: 6063-75. PMID 25026276 DOI: 10.18632/oncotarget.2168  0.48
2014 Tebbe C, Chhina J, Dar SA, Sarigiannis K, Giri S, Munkarah AR, Rattan R. Metformin limits the adipocyte tumor-promoting effect on ovarian cancer. Oncotarget. 5: 4746-64. PMID 24970804 DOI: 10.18632/oncotarget.2012  0.48
2014 Giri S, Rattan R, Deshpande M, Maguire JL, Johnson Z, Graham RP, Shridhar V. Preclinical therapeutic potential of a nitrosylating agent in the treatment of ovarian cancer. Plos One. 9: e97897. PMID 24887420 DOI: 10.1371/journal.pone.0097897  0.48
2013 Giri S, Karakoti A, Graham RP, Maguire JL, Reilly CM, Seal S, Rattan R, Shridhar V. Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer. Plos One. 8: e54578. PMID 23382918 DOI: 10.1371/journal.pone.0054578  0.48
2013 Kumar S, Meuter A, Thapa P, Langstraat C, Giri S, Chien J, Rattan R, Cliby W, Shridhar V. Metformin intake is associated with better survival in ovarian cancer: a case-control study. Cancer. 119: 555-62. PMID 23208739 DOI: 10.1002/cncr.27706  0.48
2011 Rattan R, Graham RP, Maguire JL, Giri S, Shridhar V. Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. Neoplasia (New York, N.Y.). 13: 483-91. PMID 21532889 DOI: 10.1593/neo.11148  0.48
2009 Nath N, Khan M, Rattan R, Mangalam A, Makkar RS, de Meester C, Bertrand L, Singh I, Chen Y, Viollet B, Giri S. Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity. Biochemical and Biophysical Research Communications. 386: 16-20. PMID 19486896 DOI: 10.1016/j.bbrc.2009.05.106  0.48
2006 Giri S, Rattan R, Haq E, Khan M, Yasmin R, Won JS, Key L, Singh AK, Singh I. AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutrition & Metabolism. 3: 31. PMID 16901342 DOI: 10.1186/1743-7075-3-31  0.48
2006 Giri S, Khan M, Rattan R, Singh I, Singh AK. Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death. Journal of Lipid Research. 47: 1478-92. PMID 16645197 DOI: 10.1194/jlr.M600084-JLR200  0.48
2006 Rattan R, Giri S, Singh AK, Singh I. Rho/ROCK pathway as a target of tumor therapy. Journal of Neuroscience Research. 83: 243-55. PMID 16385577 DOI: 10.1002/jnr.20707  0.48
2005 Rattan R, Giri S, Singh AK, Singh I. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. The Journal of Biological Chemistry. 280: 39582-93. PMID 16176927 DOI: 10.1074/jbc.M507443200  0.48
2004 Giri S, Rattan R, Singh AK, Singh I. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. Journal of Immunology (Baltimore, Md. : 1950). 173: 5196-208. PMID 15470065  0.48
2003 Rattan R, Giri S, Singh AK, Singh I. Rho A negatively regulates cytokine-mediated inducible nitric oxide synthase expression in brain-derived transformed cell lines: negative regulation of IKKalpha. Free Radical Biology & Medicine. 35: 1037-50. PMID 14572607  0.48
2002 Giri S, Jatana M, Rattan R, Won JS, Singh I, Singh AK. Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 661-72. PMID 11978730 DOI: 10.1096/fj.01-0798com  0.48
Show low-probability matches.